The market is seemingly slowing down, but both companies see other reasons to be optimistic about digital health investment.
The Q3 2018 was the biggest quarter yet, with $3.3B invested across 93 deals during the period.
It has found 2017 to be the record-smashing year for the industry, with the highest amount of venture funding and the most mega deals ($100M+) to date.
And 16% of the 74 companies funded in the quarter are led by women CEOs, up from 11% at the half-year mark.
This spectacular figure was propelled by the record-shattering second quarter, and a record seven deals over $100M.
Five deals were over $50 million, including PatientsLikeMe, Livongo Health, Alignment Healthcare, Nuna Health and Evariant.
The market has experienced an uptick with 13% TTM growth and almost 50% YoY growth (when compared to Q1 2015); it was also the highest Q1 since 2011.
Rock Health argues that digital biomarkers can extend the collection of population level health data and introduce longitudinal data for individual consumers.
Having a balanced number of men and women on leadership teams allows for a diversified set of opinions and perspectives that impact a company's bottom line.
2015 was a record year for industry consolidation, with M&A activity nearly doubling in volume -- there were 180 deals and $6 billion in disclosed activity.